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Effect of anemia and renal cytokine production on erythropoi-
etin production during blood-stage malaria.
Background. Renal dysfunction and severe anemia are clini-
cal complications of blood-stage malaria. Erythropoietin (Epo)
is a hormone produced by the kidney and plays an essential
role in stimulating erythrocyte production. Renal dysfunction
in malaria is associated with changes in renal cytokine levels,
which may affect the production of Epo and the alleviation of
anemia.
Methods. Resistant C57BL/6 (B6) and susceptible A/J mice
were infected with Plasmodium chabaudi AS. The levels of Epo
and cytokines were measured by enzyme-linked immunosor-
bent assay (ELISA) and the degree of anemia was determined
by hematocrit. Regression analyses were employed to estimate
the influences of anemia and renal cytokines on the production
of Epo during infection.
Results. A/J mice developed higher peak parasitemia, more
severe anemia, and succumbed as compared to B6 mice, which
survived the infection. B6 mice had higher levels of renal tumor
necrosis factor-a (TNF-a) and interleukin (IL)-10, whereas A/J
mice had higher levels of IL-12p70, granulocyte-macrophage
colony-stimulating factor (GM-CSF), IL-4, and Epo. Regres-
sion analyses revealed that kidney Epo levels were influenced
most strongly by changes in hematocrit levels. In addition, al-
beit to a much weaker degree, kidney Epo levels correlated
negatively with GM-CSF levels but positively with IL-10 levels.
Conclusion. Blood-stage malaria infection modulates the
production of renal pro- and anti-inflammatory cytokines in
resistant versus susceptible strains of mice differentially. How-
ever, despite the fluctuations of renal cytokines, the degree
of anemia is the main determinant for Epo production dur-
ing blood-stage malaria while kidney cytokines may exert sec-
ondary influences.
Malaria is the most serious parasitic disease and causes
over 300 million cases and 1 to 2 million deaths each year
in endemic areas. Severe anemia is one of the major life-
threatening manifestations of malaria, especially among
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children under the age of 5 years and pregnant women
in sub-Saharan Africa. The cause of severe malarial ane-
mia is multifactorial. Direct destruction of erythrocytes
by the Plasmodium parasite and shortened life span of un-
infected erythrocytes are considered to be leading causes
of anemia during malaria [1]. Furthermore, inappropri-
ately low reticulocytosis relative to the degree of anemia
suggests insufficient erythropoiesis during malaria [2, 3].
The etiology of insufficient erythropoiesis during malaria
is, however, not fully understood. One proposed mech-
anism is inadequate erythropoietin (Epo) production
[4, 5].
Epo is the essential growth factor that promotes ery-
thropoiesis by supporting the proliferation, differenti-
ation, and maturation of erythroid precursors. Unlike
other hematopoietic growth factors, Epo is produced pri-
marily in the kidneys instead of in the bone marrow where
target erythroid precursor cells reside. In the kidney, the
site of Epo production is localized to the peritubular
fibroblasts of the renal cortex [6–8]. It is well acknowl-
edged that tissue oxygen tension regulates Epo produc-
tion in a feedback loop, which translates into an inverse
logarithmic relationship between plasma Epo and hema-
tocrit levels [9]. However, in anemia due to renal failure,
chronic inflammation, and cancer, Epo production is not
adequate. Several proinflammatory cytokines have been
demonstrated to inhibit Epo production, including tumor
necrosis factor-a (TNF-a), interleukin (IL)-1, and IL-6
[10, 11].
Fluctuation of proinflammatory and anti-inflammatory
cytokine levels in the kidney has been reported in
malaria-related renal disorders. Malaria causes acute in-
terstitial inflammation in rodents [12]. An increase in
serum TNF-a is associated with renal failure in hu-
man malaria due to P. falciparum [13]. Immunohisto-
chemistry revealed that increased staining for TNF-a,
IL-1a, IL-6, and granulocyte-macrophage colony-
stimulating factor (GM-CSF), and decreased staining
for IL-10 are associated with malarial tubulointerstitial
nephritis in rodents [14]. On the other hand, murine
malarial glomerulonephritis is associated with increased
1640
Chang and Stevenson: Malarial anemia, renal cytokines, and Epo 1641
messenger RNA levels of TNF-a, IL-1a, IL-6, and IL-10
[15]. Although dysregulation of renal cytokine produc-
tion during malaria is well-documented, the link between
cytokine and Epo production in the kidney is not clear.
The purpose of this study was to characterize the devel-
opment of malarial anemia and the kinetics of kidney cy-
tokine production, and to analyze their relationship with
Epo production in the murine model of P. chabaudi AS
infection. Using regression analysis, we demonstrate that
during the acute phase of blood-stage P. chabaudi AS
infection in mouse strains that are either resistant or sus-
ceptible, Epo production is regulated primarily by the de-
gree of anemia whereas fluctuations in kidney cytokine
levels play a less prominent role.
METHODS
Experimental infection and animals
A/J mice, 8 to 10 weeks old, were purchased from Jack-
son Laboratories (Bar Harbor, ME, USA) and C57BL/6
(B6) mice were purchased from Charles River Labora-
tories (St. Constant, Quebec, Canada). Mice were age-
and gender-matched in all experiments. P. chabaudi AS
parasites were maintained as previously described [16].
Mice were infected intraperitoneally with 106 parasitized
red blood cells. Mice were sacrificed at the designated
time points and blood was collected. Blood smears were
prepared and stained with Diff-Quik Solution (Dade
Behring, Dudingen, Switzerland), and parasitemia was
determined by counting at least 400 cells. Furthermore,
cardiac puncture was performed and 70 lL of blood were
obtained for determination of hematocrit levels. For each
sample, the remaining blood was allowed to clot at room
temperature and centrifuged twice at 1000 × g for 10 min-
utes at room temperature for serum collection. Sera were
stored at −20◦C until tested for Epo concentrations. Kid-
neys were harvested, snap-frozen in liquid nitrogen, and
stored at −70◦C until tissue processing. All animal ma-
nipulations were done in accordance with the animal care
guidelines implemented by the McGill University Health
Centre Research Institute.
Kidney homogenization
Kidneys were thawed in 2 mL sterile phosphate-
buffered saline (PBS) and homogenized three times for
15 seconds with a Brinkmann homogenizer (Brinkmann
Instruments, Mississauga, Ontario, Canada). Kidney ho-
mogenates were then subjected to three freeze-thaw cy-
cles at −70◦C for 4 hours and 37◦C for 15 minutes. Super-
natants were separated from tissue residues by centrifu-
gation twice at 12,000g for 10 minutes at 4◦C.
Determination of protein, Epo, and
cytokine concentrations
Total protein concentrations in supernatants of kidney
homogenates were measured using a Bio-Rad Protein
Assay Kit (Bio-Rad Laboratories, Hercules, CA, USA)
following the manufacturer’s instructions. Epo concen-
trations in supernatants of kidney homogenates and sera
were measured by a murine Epo-specific enzyme-linked
immunosorbent assay (ELISA) recently developed in our
laboratory [17]. Monoclonal rat anti-mouse Epo antibody
(BD BioSciences, Mississauga, Ontario, Canada) and
polyclonal rabbit antihuman Epo antibody (R&D Sys-
tems, Minneapolis, MN, USA) were used as capturing and
detecting antibody, respectively. Recombinant murine
Epo was purchased from Boehringer Mannheim-Roche
(Laval, Quebec, Canada). Levels of TNF-a, interferon-
c (IFN-c), IL-12p70, GM-CSF, IL-10, and IL-4 in su-
pernatants of kidney homogenates were determined by
sandwich ELISA using paired capture and detection an-
tibodies as previously described [18–20]. Reactivity was
revealed using ABTS substrate (Boehringer Mannheim-
Roche) and optical density (OD) values were read at a
wavelength of 405 nm with 492 nm as reference. The con-
centrations of cytokine in the samples were calculated
against standard curves generated using recombinant cy-
tokines (BD PharMingen, Mississauga, Ontario, Canada)
and expressed as per mg of renal protein. Renal IFN-c
was undetectable and thus was not included in statistical
analyses.
Statistical analyses
Values are expressed as mean ± standard error of the
mean (SEM). The effects of mouse strain on the course
of blood-stage P. chabaudi AS infection were determined
with repeated measures analysis of variance (ANOVA).
Statistical significance of differences in Epo and cytokine
levels between A/J and B6 mice were analyzed by Stu-
dent t test. A P < 0.05 in the t test was considered to
be significant. Kidney and serum Epo levels were loga-
rithmically transformed before performing correlation or
regression analyses. Pearson correlation coefficient anal-
ysis was performed to determine the association between
two variables of any combinations. The hypothesis that
two variables are uncorrelated was tested and a P < 0.05
was considered to be significant. Log-transformed kidney
Epo levels were then used as the dependant variable in
multivariate regression analysis. Hematocrit levels and
the levels of cytokines at all time points were included
as independent variables. The forward selection method
of multiple regression analysis was used to determine the
regression coefficient and partial R2 of each variable. For-
ward selection with significance level set at 0.15 for the
F test was used to identify variables having significant in-
fluence on the variability of kidney Epo levels. Stepwise
selection that combined forward selection and backward
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Fig. 1. Course of parasitemia and progres-
sion of anemia during Plasmodium chabaudi
AS infection in resistant C57BL/6 (B6) and
susceptible A/J mice. Course of parasitemia
(A) and hematocrit levels (B). Values are
mean ± standard error of the mean for three
to six mice per group. ∗P < 0.05, A/J vs.
B6 mice. † Indicates mortality. Similar results
were obtained in four independent experi-
ments.
elimination was also employed and the same subsets of
variables were identified as significant by forward selec-
tion. All analyses were performed using SAS/STAT soft-
ware (SAS Institute, Cary, NC, USA).
RESULTS
Course of P. chabaudi AS infection in B6 and A/J mice
Following infection with P. chabaudi AS, parasite repli-
cation was accelerated on day 5 postinfection and para-
sitemia peaked on day 7 postinfection in both resistant B6
and susceptible A/J mice (Fig. 1A). All mice developed
anemia, which worsened following peak levels of para-
sitemia (Fig. 1B). A/J mice had significantly higher peak
parasitemia, suffered earlier onset and more severe ane-
mia, and succumbed by day 8 to 9 postinfection when they
were most anemic. In contrast, B6 mice controlled acute
infection by 2 weeks, and their hematocrit levels began
to increase by day 9 to 11 postinfection and returned to
85% of preinfection normal level by day 14 postinfection.
Renal proinflammatory and anti-inflammatory cytokine
production during P. chabaudi AS infection
The kidneys of both infected B6 and A/J mice were
discolored and appeared puffy with edema as compared
to those collected from normal mice (unpublished per-
sonal observations). Determination of cytokine levels in
the supernatants of kidney homogenates by ELISA re-
vealed that infection led to increased TNF-a production
in both resistant B6 and susceptible A/J mice (Fig. 2A).
B6 mice had a significantly higher level of renal TNF-a
on day 6 postinfection as compared to A/J mice. Renal
TNF-a production in B6 mice peaked on day 8 postin-
fection and remained significantly higher than baseline
levels until day 14 postinfection (P < 0.05 for days 8 to 14
postinfection vs. day 0 postinfection). For A/J mice, the
increase in renal TNF-a was delayed in comparison to B6
mice and reached the peak level on day 9 postinfection
when mortality occurred. However, there were no signif-
icant differences in peak TNF-a levels between B6 and
A/J mice.
In contrast to the kinetics of renal TNF-a production,
the increases in renal IL-12p70 level were transient in
both strains of mice, and peaked on day 5 postinfection
(Fig. 2B). A secondary peak was also observed in both
strains of mice, which occurred on day 8 postinfection in
A/J mice and on day 11 postinfection in B6 mice. The
level of IL-12p70 in kidney was significantly higher in
A/J than B6 mice on day 8 postinfection. Renal GM-
CSF production followed a similar pattern of kinetics in
A/J and B6 mice (Fig. 2C). Both strains had a primary
peak of GM-CSF on day 5 postinfection, followed by a
secondary peak which occurred on day 8 postinfection in
A/J mice and on day 11 postinfection in B6 mice. There
was a significant difference between A/J and B6 mice on
day 8 postinfection.
In addition to up-regulated production of proinflam-
matory cytokines in the kidneys, production of the
anti-inflammatory cytokine, IL-10, was also transiently
increased (Fig. 2D). There were no significant differences
throughout the infection between B6 and A/J mice ex-
cept on day 5 postinfection, when the renal IL-10 level
was significantly higher in B6 compared to A/J mice.
The levels of IL-4, the signature Th2 cytokine, were also
measured. Primary and secondary peaks were observed
on day 5 and day 11 postinfection, respectively, in B6 mice
(Fig. 2E). However, due to high within-group variability
in B6 mice, there were no significant differences when
comparing these time points with the baseline level at day
0. In contrast, A/J mice had two peaks of renal IL-4 pro-
duction on day 5 and day 8 postinfection, and the levels at
both time points were significantly higher in comparison
to the day 0 baseline level (P < 0.05 day 5 postinfection
vs. day 0 postinfection, P < 0.05 day 8 postinfection vs.
day 0 postinfection). By day 9 postinfection, when mor-
tality occurred in A/J mice, the IL-4 level was still sig-
nificantly higher compared to baseline (P < 0.05). When
comparing A/J to B6 mice, A/J mice had a significantly
higher level of renal IL-4 on day 8 postinfection.
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Fig. 2. Kinetics of renal cytokine pro-
duction during Plasmodium chabaudi
AS infection in resistant C57BL/6 (B6)
and susceptible A/J mice. Levels of
tumor necrosis factor-a (TNF-a) (A),
interleukin (IL)-12p70 (B), granulocyte-
macrophage colony-stimulating factor
(GM-CSF) (C), IL-10 (D), and IL-4 (E) in
the supernatants of kidney homogenates.
Values are mean ± standard error of the
mean for three to six mice per group. ∗P <
0.05, A/J vs. B6 mice. Similar results were
obtained in two independent experiments.
Levels of renal and serum Epo during P. chabaudi
AS infection
Epo concentrations in the supernatants of kidney ho-
mogenates and sera were measured by ELISA. As pre-
sented in Figure 3, there were significant increases in Epo
production in the kidneys of both mouse strains follow-
ing the development of malarial anemia on days 6 and 7
postinfection (Fig. 3A). Consistent with earlier onset and
more severe anemia, significantly higher levels of Epo
were detected in kidney homogenates of A/J mice, which
reached a peak level on day 9 postinfection when these
mice were most anemic. In contrast, increased Epo pro-
duction was transient in B6 mice and Epo levels returned
to baseline when anemia was alleviated by days 11 to 14
postinfection. The concentration of Epo in serum sam-
ples (Fig. 3B) showed similar trends as those detected in
kidney homogenates. A/J mice had significantly higher
levels of serum Epo levels on days 6, 7, and 9 postinfec-
tion compared to B6 mice. Correlation analysis revealed
that serum Epo levels were significantly correlated with
kidney Epo levels (correlation coefficient rs = 0.88 for
A/J, P < 0.001; rs = 0.83 for B6, P < 0.001).
Correlation analyses among kidney Epo levels, degree
of anemia, and renal cytokine production
Univariate analysis. Among kidney cytokines, sim-
ple correlation analysis showed that the production of
IL-12p70, GM-CSF, and IL-4 strongly correlated with
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Fig. 3. Kinetics of erythropoietin (Epo) levels during Plasmodium chabaudi AS infection in resistant C57BL/6 (B6) and susceptible A/J mice.
Epo levels in kidneys (A), Epo levels in sera (B), and regression analysis (C) for relationship between kidney Epo levels and hematocrit levels.
Values are means ± standard error of the mean for three to six mice per group per time point except for (C) in which N = 27 for B6 mice and N =
24 for A/J mice. ∗P < 0.05, A/J vs. B6 mice. Similar results were obtained in replicate experiment.
Table 1. Correlation coefficient (rs) of association between two
variables among renal erythropoietin, hematocrit, and renal cytokine
levels in univariate analysisa
Epo TNF-a IL-12p70 GM-CSF IL-10
B6 Mice (N = 27)
Hematocrit −0.83b
TNF-a 0.60b
IL-12p70 −0.29 −0.34
GM-CSF −0.36 −0.42b 0.96b
IL-10 0.38b 0.18 0.32 0.26
IL-4 −0.23 −0.34 0.92b 0.89b 0.32
A/J Mice (N = 24)
Hematocrit −0.84b
TNF-a 0.69b
IL-12p70 −0.14 −0.14
GM-CSF −0.38 −0.34 0.78b
IL-10 0.52b 0.30 0.11 −0.23
IL-4 −0.05 −0.17 0.87b 0.72b 0.16
Abbreviations are: B6, C57BL/6; Epo, erythropoietin; TNF-a, tumor necrosis
factor-a; IL, interleukin; GM-CSF, granulocyte-macrophage colony-stimulating
factor.
aPearson correlation coefficient analysis was performed to determine the asso-
ciation between two variables of various combinations. The hypothesis that two
variables are not correlated was tested and P < 0.05 was considered to be signifi-
cant.
bP < 0.05.
each other in both B6 and A/J mice (Table 1). However,
none of these three cytokines showed significant correla-
tion with Epo production in either mouse strain in uni-
variate correlation analysis. Surprisingly, Epo production
strongly correlated with renal TNF-a levels and modestly
correlated with IL-10 levels in both mouse strains. The
strongest associations found were negative correlations
between Epo production and hematocrit levels in B6 as
well as A/J mice. As shown in Fig. 3C, the regression lines
were not significantly different between B6 and A/J mice.
Multivariate analysis. To delineate the potential con-
tribution of each variable to kidney Epo levels while
adjusting for interactions among variables, multiple re-
Table 2. Regression coefficients and partial R2 of individual variables
derived from multivariate regression analysisa
B6 (N = 27) A/J (N = 24)
Regression Partial Regression Partial
coefficient R2 coefficient R2
Hematocrit −0.018 0.683b −0.021 0.707b
TNF-a −0.293 0.003 −0.443 0.005
IL-12p70 0.137 0.018 0.047 0.002
GM-CSF −0.859 0.013 −0.834 0.142b
IL-10 0.015 0.063b 0.006 0.018b
IL-4 −1.984 0.011 −0.981 0.003
Abbreviations are: B6, C57BL/6; TNF-a, tumor necrosis factor-a; IL,
interleukin; GM-CSF, granulocyte-macrophage colony-stimulating factor.
aLog-transformed kidney erythropoietin levels were used as the dependant
variable. Multivariate regression analysis with forward selection was performed
to determine regression coefficient and partial R2 for individual variables.
bIndicates variable meets the 0.15 significance level for the F tests used to
judge for entry into the forward selection methods of multivariate regression
analysis model.
gression analysis was conducted with forward selection
to add in variables one at a time. When the levels of
hematocrit, TNF-a, IL-12p70, GM-CSF, IL-10, and IL-4
were all included in the regression model, kidney Epo was
negatively associated with hematocrit, TNF-a, GM-CSF,
and IL-4, while positively associated with the level of IL-
12p70 and IL-10 in both strains of mice (Table 2). Deter-
mination of partial R2 contributed by individual variables
suggested that hematocrit level was the single most im-
portant variable in predicting kidney Epo level. With the
level of significance for the F test set at 0.15, two cytokines
were found to be significantly associated with kidney Epo
level in A/J mice. GM-CSF was negatively associated and
IL-10 was positively associated with kidney Epo level. In
B6 mice, IL-10 was the only cytokine significantly associ-
ated with kidney Epo level. TNF-a, IL-12p70, and IL-4
did not significantly correlate with kidney Epo level in
either mouse strain.
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DISCUSSION
The major symptoms during blood-stage malaria are
associated with the replication of the Plasmodium par-
asites inside host red cells and the subsequent destruc-
tion of the red cells as the parasites mature. The clinical
complications caused by Plasmodium parasites are not
restricted to hematologic disorders. In addition to ane-
mia, malaria infection can cause a full spectrum of clini-
cal manifestations, which may involve other organs such
as brain [21], lung [22], and kidney [12, 14, 15, 23]. Al-
though numerous studies have been conducted to inves-
tigate the pathophysiologic impact of malaria on specific
organs, the potential effect of changes in one organ on
another tissue during infection has rarely been investi-
gated. In this context, the kidney is an essential tissue not
only for regulating the balance of water, sodium, potas-
sium, and calcium, but also for maintaining constant red
cell volume by producing Epo, the principal growth fac-
tor that promotes erythropoiesis. When anemia occurs,
decreased tissue oxygen tension up-regulates Epo pro-
duction in the kidney. Epo is then transported via the
circulation to hematopoietic tissues to promote erythro-
poiesis. The net effect of this cascade of events is allevi-
ation of anemia. As anemia is a frequent complication
among malaria patients and also occurs in experimen-
tal animal models, kidney dysfunction during blood-stage
malaria may have a profound effect on the outcome of
malarial anemia.
In this study, we characterized the kinetics of proin-
flammatory and anti-inflammatory cytokine production
in the kidney during acute blood-stage P. chabaudi AS in-
fection. Consistent with the results of studies on nephritis
associated with P. berghei ANKA infection in mice [14,
15], we identified increased levels of renal TNF-a follow-
ing infection. However, increased renal TNF-a produc-
tion was not associated with fatal outcome of the infection
as resistant B6 mice produced more TNF-a on day 6
postinfection in comparison to susceptible A/J mice. We
also observed an increase in the levels of renal GM-CSF
in both B6 and A/J mice. This cytokine has been proposed
to be responsible for mesangial cell proliferation and in-
filtration of pigmented macrophages into the glomeruli
during malaria infection [15]. In addition, increased lev-
els of IL-10 were detected in both resistant B6 and sus-
ceptible A/J mice. The role of IL-10 in the pathogenesis
of malarial nephritis is unclear. Previous studies indicate
that IL-10 may contribute to tubulointerstitial nephritis
and glomerulonephritis during murine malaria [14, 15].
Additionally, we observed increased production of IL-
12p70 in both strains of mice, and of IL-4 in A/J mice.
Increased production of IL-12p70 and IL-4 in the kid-
ney during malaria has not been described previously.
However, it has been suggested that IL-12 causes re-
nal injury in crescentic glomerulonephritis and that in-
creased serum IL-4 is associated with the development
of lupus nephritis [24, 25]. The presence of IL-12 and
IL-4 in the kidney during malaria may cause renal injury
in a similar fashion, possibly by acting on the infiltrating
inflammatory cells, including CD4+ and CD8+ T cells
and macrophages [12].
Cytokine regulation of Epo production is not fully un-
derstood, partially due to the difficulty of culturing Epo-
producing renal cells. An in vitro study performed by
Jelkmann et al [10] using kidney perfusion suggests that
IL-1, IL-6 and TNF-a suppress Epo production. Further-
more, treatment of cancer patients with TNF-a has been
linked to decreased Epo production [11]. However, the
in vivo effect of increased cytokine production in the kid-
ney on Epo production during disease states has never
been investigated. Univariate analysis of our data in the
P. chabaudi AS model revealed an inverse relationship
between the levels of kidney Epo and hematocrit. Our
data are consistent with the paradigm of feedback reg-
ulation of Epo production by red cell volume [9]. Our
data are also consistent with the results of other malaria-
related studies despite the controversy regarding the ade-
quacy of Epo production relative to the degree of malarial
anemia [4, 5, 16, 26–28].
In contrast to the proposed inhibition of Epo produc-
tion by TNF-a [10, 11], univariate analysis showed a pos-
itive correlation between renal TNF-a and Epo levels
during malaria in the present study. In addition, a posi-
tive association was also observed between renal IL-10
and Epo levels. As multiple factors may be involved in
the regulation of Epo production during malaria, multi-
variate analysis was then conducted to take into consid-
eration the interaction among hematocrit level and the
levels of proinflammatory and anti-inflammatory cy-
tokines. Hematocrit level was demonstrated to be the
strongest variable in determining kidney Epo production
during P. chabaudi AS infection in both resistant B6 and
susceptible A/J mice. When the influence of hematocrit
level was taken into account, TNF-a no longer correlated
positively with kidney Epo level. In fact, a weak negative
correlation was found between the levels of renal TNF-a
and Epo, but it did not reach statistical significance. The
lack of a strong inhibitory effect of TNF-a as suggested
by the study of Jelkmann et al [10] may be due to the
relatively low concentration of TNF-a detected in our
study in comparison to the massive dose of exogenous
TNF-a used in kidney perfusion in vitro. It is also possi-
ble that the TNF-a–producing renal cells may not be lo-
cated in close enough proximity to Epo-producing cells to
exert their inhibitory effect. However, multivariate anal-
ysis revealed that GM-CSF levels negatively correlated
with levels of Epo in A/J but not B6 mice. GM-CSF may
be responsible for infiltration of macrophages into the
glomeruli during malaria infection [15], but its poten-
tial inhibitory effect on Epo production requires further
investigation. In addition, the positive correlation be-
tween renal IL-10 and Epo levels, revealed by univariate
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analysis, remained valid in multivariate analysis in both
strains of mice. Based on these analyses, we postulate
that IL-10 may have a stimulatory effect on Epo produc-
tion. However, IL-10 appears to exert less influence on
Epo production in comparison to the strong influence of
hematocrit. The role of IL-10 in Epo production during
blood-stage malaria can be further investigated using IL-
10−/− mice.
Thus, our study revealed a significant and strong effect
of hematocrit level and a weak influence of proinflamma-
tory and anti-inflammatory cytokines on Epo production
during malaria infection. This explains, at least partially,
the lack of significant differences in the logarithmic in-
verse relationships between Epo level and the degree of
anemia in resistant B6 mice versus susceptible A/J mice,
despite the differences in their kidney cytokine produc-
tion profile. Because comparable levels of Epo relative
to the degree of anemia were produced in both A/J and
B6 mice during infection, insufficient erythropoiesis in
A/J mice observed in our previous study [16] was not due
to differential Epo production. Taken together, our data
demonstrate that the acute phase of blood-stage malaria
infection causes an increase in proinflammatory and anti-
inflammatory cytokine production in the kidney. Our data
also suggest that during blood-stage malaria infection,
Epo production is strongly regulated by the degree of
anemia. In addition, production of kidney cytokines, es-
pecially IL-10, and in susceptible A/J mice, GM-CSF, ex-
erts minor influences.
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